MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_on1225931346
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu|||unuuu
008 201207s2020 enk o 000 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d YDX  |d UKAHL  |d UKMGB  |d CUY  |d OCLCF  |d EBLCP  |d OCLCO  |d OCLCQ  |d OCLCO  |d K6U  |d OCLCQ  |d OCLCO 
015 |a GBC080031  |2 bnb 
016 7 |a 019826557  |2 Uk 
019 |a 1176323646  |a 1178640994  |a 1191054543 
020 |a 9781789061826  |q (electronic bk.) 
020 |a 1789061822  |q (electronic bk.) 
020 |z 9781789061819 
020 |z 1789061814 
029 1 |a UKMGB  |b 019826557 
029 1 |a AU@  |b 000072395334 
029 1 |a AU@  |b 000067973777 
035 |a (OCoLC)1225931346  |z (OCoLC)1176323646  |z (OCoLC)1178640994  |z (OCoLC)1191054543 
037 |a 9781789061826  |b IWA Publishing 
050 4 |a TD420 
082 0 4 |a 363.7394  |2 23 
049 |a UAMI 
245 0 0 |a Pharmaceutical residues in freshwater :  |b hazards and policy responses. 
264 1 |a London :  |b IWA Publishing,  |c 2020. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a OECD studies on water 
588 0 |a Online resource; title from PDF title page (EBSCO, viewed December 9, 2020). 
505 0 |a Cover -- Copyright -- Table of contents -- Foreword -- Acknowledgements -- Abbreviations -- Executive Summary -- Advances in monitoring can help close the knowledge gap and support policy responses -- Moving towards proactive policy action to curb pharmaceutical pollution -- OECD Policy Recommendations on addressing pharmaceutical residues in freshwater -- Cross-cutting recommendations -- Source-directed recommendations. Pharmaceutical life cycle stages: design, marketing authorisation, manufacturing, post-authorisation 
505 8 |a Use-orientated recommendations. Pharmaceutical life cycle stages: Prescription and use -- End-of-pipe recommendations. Pharmaceutical life cycle stages: collection and disposal, and wastewater treatment and reuse -- 1. Defining the challenge of managing pharmaceuticals in water -- 1.1. Key messages -- 1.2. Introduction -- 1.3. Origins, entry-pathways, sinks and concentration patterns of pharmaceuticals in the environment -- 1.4. Effects of pharmaceuticals in the environment on human and freshwater ecosystem health -- References -- Notes 
505 8 |a 2. Opportunities to build a policy-relevant knowledge base -- 2.1. Key messages -- 2.2. Environmental risk assessment and authorisation of pharmaceuticals -- 2.3. Existing frameworks for monitoring pharmaceuticals in water -- 2.4. Advances in water quality monitoring and potential benefits for risk assessments and water quality policy making -- 2.5. The added value of system modelling -- References -- Notes -- 3. Emerging policy instruments for the control of pharmaceuticals in water -- 3.1. Key messages -- 3.2. Introduction -- 3.3. Source-directed approaches -- 3.4. Use-orientated approaches 
505 8 |a 3.5. End-of-pipe measures -- References -- 4. Recommendations for the management of pharmaceuticals in freshwater -- 4.1. Key messages: A life cycle, multi-sector approach to managing pharmaceutical residues in freshwater -- 4.2. A policy toolbox for a life cycle, multi-sector approach -- 4.3. The interlinkages between freshwater, pharmaceutical, and human and animal health policies -- 4.4. A life cycle, multi-sector approach: Experience from selected OECD countries -- References -- Notes -- Glossary 
520 |b This report calls for a better understanding of the effects of pharmaceutical residues in the environment, greater international collaboration and accountability distribution, and policy actions to prevent and remedy emerging concerns. Laboratory and field tests show traces of oral contraceptives causing the feminisation of fish and amphibians, and residues of psychiatric drugs altering fish behaviour. Antimicrobial resistance, linked to the overuse of antibiotics, has rapidly escalated into a global health crisis. Unless adequate measures are taken to manage the risks, pharmaceutical residues will increasingly be released into the environment as ageing populations, advances in healthcare, and intensification of meat and fish production spur the demand for pharmaceuticals worldwide. The report outlines a collective, life?cycle approach to managing pharmaceuticals in the environment. A policy mix of source?directed, use?orientated and end?of?pipe measures, involving several policy sectors, can help to improve health and protect the environment. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Water  |x Pollution. 
650 0 |a Water  |x Pollution  |x Government policy. 
650 0 |a Drugs  |x Environmental aspects. 
650 0 |a Freshwater ecology. 
650 0 |a Water  |x Pollution  |x Toxicology. 
650 0 |a Aquatic organisms  |x Effect of water pollution on. 
650 6 |a Médicaments  |x Aspect de l'environnement. 
650 6 |a Écologie d'eau douce. 
650 6 |a Organismes aquatiques  |x Effets de la pollution de l'eau sur. 
650 7 |a Water supply & treatment.  |2 bicssc 
650 7 |a Aquatic organisms  |x Effect of water pollution on  |2 fast 
650 7 |a Freshwater ecology  |2 fast 
650 7 |a Water  |x Pollution  |2 fast 
650 7 |a Water  |x Pollution  |x Government policy  |2 fast 
650 7 |a Water  |x Pollution  |x Toxicology  |2 fast 
650 7 |a Water supply & treatment.  |2 thema 
650 7 |a Environment and Ecology.  |2 ukslc 
776 0 8 |i Print version:  |t Pharmaceutical residues in freshwater.  |d London : IWA Publishing, 2020  |z 1789061814  |z 9781789061819  |w (OCoLC)1158489476 
830 0 |a OECD studies on water. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=6265126  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH37445889 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL6265126 
938 |a EBSCOhost  |b EBSC  |n 2527563 
938 |a YBP Library Services  |b YANK  |n 16850522 
994 |a 92  |b IZTAP